Molecular Mechanisms of Childhood Overgrowth

Katrina Tatton–Brown1, Rosanna Weksberg
1Correspondence to: Katrina Tatton-Brown, Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. E-mail: [email protected]

Tóm tắt

AbstractThis issue of the Seminar Series C is dedicated to the molecular mechanisms of childhood overgrowth and celebrates the last decade of unprecedented gene discovery. Constitutional gene disorders, somatic gene disorders and imprinting dysregulation are each considered. The constitutional overgrowth genes discussed include NSD1, EZH2, GPC3, DIS3L2, and PTEN whilst the somatic overgrowth genes include AKT3, PIK3R2, and PIK3CA. Abnormalities of imprinting, exemplified by disruption of the (epi)genetic regulation of the imprinted 11p15 gene cluster, constitutes the final section of this issue. Many of the genes discussed in this issue encode components of the PI3K/mTOR growth regulatory pathway. This signaling cascade consists of dual, parallel branches, anchored by the serine–threonine kinase, mTOR, and has diverse downstream effects including inhibition of apoptosis, activation of protein synthesis, and enhanced cell survival. Activation of the PI3K/mTOR pathway promotes growth whereas inhibition, or abrogation, results in decreased cellular growth. Despite the rapid advances of the last decade, there is still an enormous amount to discover. We hope that some of the work reviewed in this issue will facilitate the next decade's discoveries and we look forward to a 10 years as productive as the last. © 2013 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B

10.1038/ng.1071

Beighton P, 1988, Inherited disorders of the skeleton

10.1038/sj.ejhg.5201638

10.1042/bst0310292

10.1146/annurev.pathol.4.110807.092311

10.1016/B978-0-12-751860-2.50017-6

10.1038/ng2083

10.1038/nrg1879

10.1016/j.ajhg.2011.11.018

10.1016/S0190-9622(87)80249-9

10.1002/ajmg.a.33835

10.1038/ng863

10.1056/NEJMoa1104017

10.1038/ejhg.2009.162

10.1016/j.ajhg.2010.07.001

10.1016/S1097-2765(02)00568-3

10.1136/jmedgenet-2011-100534

10.1136/jmg.34.9.719

10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C

10.1038/ng0396-241

10.1038/sj.ejhg.5201613

10.1038/ng.2331

10.1016/j.cub.2004.06.054

10.1016/j.ceb.2005.09.009

10.1002/ajmg.a.34427

10.1677/erc.0.0080237

10.1002/ajmg.a.32534

10.18632/oncotarget.385

10.1016/j.ejmg.2011.06.004

10.1016/j.ejmg.2010.02.003

Weaver DD, 1994, Overgrowth syndromes and disorders: Definition, classification and discussion, Growth Gen Horm, 10, 1